Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
102.37
-0.11 (-0.11%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
21
22
Next >
10 Health Care Stocks Whale Activity In Today's Session
↗
March 04, 2024
Via
Benzinga
7 Stable Stocks to Buy for 100% Returns by 2025
↗
March 04, 2024
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.
Via
InvestorPlace
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
↗
March 03, 2024
While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential.
Via
InvestorPlace
3 Hot Stocks Bought by Members of Congress: Follow the Money
March 01, 2024
Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February;
Via
MarketBeat
Earnings Scheduled For February 21, 2024
↗
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Earnings Preview For Exact Sciences
↗
February 20, 2024
Via
Benzinga
Cathie Wood Is Selling This Stock: Should You?
↗
February 07, 2024
This company hasn't performed well in the past 12 months.
Via
The Motley Fool
A Glimpse Into The Expert Outlook On Exact Sciences Through 5 Analysts
↗
January 02, 2024
Via
Benzinga
Exact Sciences to Participate in March Investor Conference
February 26, 2024
From
Exact Sciences Corp.
Via
Business Wire
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
↗
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.
Via
Benzinga
Topics
Economy
Stocks
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
↗
February 22, 2024
EXAS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
5 Analysts Have This to Say About Exact Sciences
↗
December 14, 2023
Via
Benzinga
Exact Sciences Announces Fourth Quarter 2023 Results
February 21, 2024
From
Exact Sciences Corp.
Via
Business Wire
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
↗
February 21, 2024
The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.
Via
Benzinga
Topics
Economy
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 02, 2024
--News Direct--
Via
News Direct
Topics
Death
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
↗
February 01, 2024
The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the...
Via
Benzinga
Topics
Death
Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
February 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Stocks to Buy for the Age of Personalized Medicine
↗
January 28, 2024
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.
Via
InvestorPlace
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
↗
January 22, 2024
These stocks can reward patient investors.
Via
The Motley Fool
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
↗
January 18, 2024
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.
Via
InvestorPlace
Time to buy these 3 healthcare companies that raised revenue guidance?
January 16, 2024
The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.
Via
MarketBeat
Cathie Wood's Ark Invest Acquires Over $25.5 Million Worth Of Tesla Shares — Sells Coinbase And Robinhood Stock A Day After Bitcoin Spot ETF Approval
↗
January 12, 2024
On Thursday, Cathie Wood-led Ark Invest made a significant move in the stock market, purchasing $25.55 million worth of shares in Tesla Inc (NASDAQ:TSLA).
Via
Benzinga
Topics
ETFs
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
↗
January 08, 2024
Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.
Via
InvestorPlace
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock
↗
January 02, 2024
Via
Benzinga
Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday?
↗
December 20, 2023
Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs.
Via
Benzinga
What's Going On With Exact Sciences Stock?
↗
December 20, 2023
Exact Sciences Corporation (NASDAQ: EXAS) shares are trading higher Wednesday, and the stock has gained over 8% in the past month. Here's a look at the latest Exact Sciences news: What To Know:
Via
Benzinga
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
↗
December 20, 2023
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Is This BioTech Play Severely Undervalued? BioTech Shares Promising Results From Colorectal Study
↗
December 19, 2023
Via
Benzinga
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
↗
December 17, 2023
If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right?
Via
The Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
↗
December 13, 2023
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
